FDA panel backs much-debated ALS drug in rare review
A panel of federal health advisers has voted to recommend approval for an experimental drug to treat Lou Gehrig's disease.
Stay updated with breaking news from Billy Dunn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A panel of federal health advisers has voted to recommend approval for an experimental drug to treat Lou Gehrig's disease.
In a remarkable turnaround, a panel of federal health advisers has voted to recommend approval for an experimental drug to treat Lou Gehrig's disease. Patients and their families have rallied behind Amylyx's drug, urging approval.
The group’s 7-2 ruling in favor of the therapeutic represents a shift from previous deliberations, in which data on its effectiveness was deemed insufficient.
Patients with the deadly neurological disease have rallied behind the drug from Amylyx Pharma and are lobbying the FDA for approval.
WASHINGTON (AP) — A panel of federal health advisers voted Wednesday to recommend...